Back to search
Stage II Nasopharyngeal Carcinoma AJCC v8
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Stage II Nasopharyngeal Carcinoma AJCC v8 trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Stage II Nasopharyngeal Carcinoma AJCC v8 trials you may qualify forThis phase II trial tests the addition of BMS-986016 (relatlimab) to the usual immunotherapy after initial treatment for nasopharyngeal cancer that has come bac…
This phase II trial compares the effectiveness of adding BMX-001 to usual symptom management versus usual symptom management alone for reducing oral mucositis i…
This phase II trial tests effects of nivolumab in combination with chemotherapy drugs prior to radiation therapy patients with nasopharyngeal carcinoma (NPC). I…
This trial uses blood tests and questionnaires to study how well participants with head and neck cancer that has spread to other places in the body adhere to sw…
This phase II trial tests how well lovastatin and pembrolizumab work in treating patients with head and neck cancer that has come back after a period of improve…
The goal of this study is to learn the efficacy and safety of nimotuzumab combined with toripalimab and gemcitabine/cisplatin regimen treatment recurrent/distan…
This phase II/III compares the standard therapy (chemotherapy plus cetuximab) versus adding bevacizumab to standard chemotherapy, versus combination of just bev…
This phase I trial studies the side effects of image-guided hyper-fractioned proton therapy in treating patients with head and neck cancer that has spread to ne…